Wendy Cameron
Direktor/Vorstandsmitglied bei Beijing Tong Ren Tang Ming Qi Group LLC
Aktive Positionen von Wendy Cameron
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Beijing Tong Ren Tang Ming Qi Group LLC | Direktor/Vorstandsmitglied | 01.01.2003 | - |
Corporate Officer/Principal | 23.10.2009 | - |
Karriereverlauf von Wendy Cameron
Ehemalige bekannte Positionen von Wendy Cameron
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.2002 | 29.06.2018 |
Independent Dir/Board Member | 01.01.2002 | 29.06.2018 | |
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Direktor/Vorstandsmitglied | 01.01.2002 | 02.10.2007 |
Cameron Coca Cola Bottling Co.
Cameron Coca Cola Bottling Co. Beverages: Non-AlcoholicConsumer Non-Durables Part of The Coca-Cola Co., Cameron Coca Cola Bottling Co. bottles Coca-Cola soft drink products. Cameron Coca Cola Bottling was acquired by Coca-Cola Enterprises, Inc. /Old/ on October 21, 1998. | General Counsel | 01.01.1981 | 01.01.1998 |
Vertrieb & Marketing | 01.01.1981 | 01.01.1998 | |
Washington Hospital Healthcare System
Washington Hospital Healthcare System Hospital/Nursing ManagementHealth Services The American company was founded in 1985. The CEO is Kimberly Hartz. | Vorsitzender | 14.07.2011 | - |
Washington Health System Foundation
Washington Health System Foundation Investment Trusts/Mutual FundsMiscellaneous Part of University of Pittsburgh Medical Center, Washington Health System Foundation is a foundation or endowment. Washington Health System Foundation is based in Washington, PA. Washington Health System Foundation was acquired by University of Pittsburgh Medical Center on June 01, 2024. | Direktor/Vorstandsmitglied | 13.05.2010 | - |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Direktor/Vorstandsmitglied | 01.01.2002 | - |
Independent Dir/Board Member | 13.07.2011 | - |
Ausbildung von Wendy Cameron
Otterbein College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 5 |
Independent Dir/Board Member | 2 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 4 |
Consumer Non-Durables | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 7 |
---|---|
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Health Technology |
Beijing Tong Ren Tang Ming Qi Group LLC | |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
Cameron Coca Cola Bottling Co.
Cameron Coca Cola Bottling Co. Beverages: Non-AlcoholicConsumer Non-Durables Part of The Coca-Cola Co., Cameron Coca Cola Bottling Co. bottles Coca-Cola soft drink products. Cameron Coca Cola Bottling was acquired by Coca-Cola Enterprises, Inc. /Old/ on October 21, 1998. | Consumer Non-Durables |
Washington Health System Foundation
Washington Health System Foundation Investment Trusts/Mutual FundsMiscellaneous Part of University of Pittsburgh Medical Center, Washington Health System Foundation is a foundation or endowment. Washington Health System Foundation is based in Washington, PA. Washington Health System Foundation was acquired by University of Pittsburgh Medical Center on June 01, 2024. | Miscellaneous |
Washington Hospital Healthcare System
Washington Hospital Healthcare System Hospital/Nursing ManagementHealth Services The American company was founded in 1985. The CEO is Kimberly Hartz. | Health Services |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Wendy Cameron
- Erfahrung